Dactolisib
- Generic Name
- Dactolisib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H23N5O
- CAS Number
- 915019-65-7
- Unique Ingredient Identifier
- RUJ6Z9Y0DT
- Background
Dactolisib has been used in trials studying the treatment of Cancer, Solid Tumor, Renal Cancer, Breast Cancer, and Cowden Syndrome, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath